T.131. Disseminated Common Warts in Idiopathic CD4 Lymphocytopenia Patients: Response to Treatment with Interferon-alpha (original) (raw)
Protective and Therapeutic Role for α B-Crystallin in Autoimmune Demyelination
Lawrence Steinman
Clinical Immunology, 2007
View PDFchevron_right
EBV-induced expression and HLA-DR-restricted presentation by human B cells of alpha B-crystallin, a candidate autoantigen in multiple sclerosis
Marianne van Stipdonk
Journal of immunology (Baltimore, Md. : 1950), 1999
View PDFchevron_right
EBV-Induced Expression and HLA-DR-Restricted Presentation by Human B Cells of αB-Crystallin, a Candidate Autoantigen in Multiple Sclerosis
Johannes van Noort
The Journal of Immunology, 1999
View PDFchevron_right
Chaperone Activity of α B-Crystallin Is Responsible for Its Incorrect Assignment as an Autoantigen in Multiple Sclerosis
Jonathan Rothbard
Journal of Immunology, 2011
View PDFchevron_right
Therapeutic effects of systemic administration of the chaperone alpha B crystallin associated with binding proinflammatory plasma proteins
Rong Chen
2012
View PDFchevron_right
Advances in the Treatment of Autoimmune Diseases Cellular Activity, Type-1/Type-2 Cytokine Secretion Patterns and their Modulation by Therapeutic Peptides
Athanasia Mouzaki
Current medicinal …, 2005
View PDFchevron_right
Current and future approaches to the treatment of immunologic diseases: new targets and new therapeutic agents
David Fox
Translational research : the journal of laboratory and clinical medicine, 2015
View PDFchevron_right
Therapeutic Effects of Systemic Administration of Chaperone B-Crystallin Associated with Binding Proinflammatory Plasma Proteins
Sara Brownell
Journal of Biological Chemistry, 2012
View PDFchevron_right
Chaperone Activity of B-Crystallin Is Responsible for Its Incorrect Assignment as an Autoantigen in Multiple Sclerosis
Jonathan Rothbard, Michael Kurnellas
The Journal of Immunology, 2011
View PDFchevron_right
Encephalitogenic and immunogenic potential of the stress protein αB-crystallin in Biozzi ABH (H-2Ag7) mice
Johannes van Noort, Marianne van Stipdonk, Kirsty McCormack
Journal of Neuroimmunology, 2000
View PDFchevron_right
Response to Comment on "Chaperone Activity of B-Crystallin Is Responsible for Its Incorrect Assignment as an Autoantigen in Multiple Sclerosis
Jonathan Rothbard
The Journal of Immunology, 2011
View PDFchevron_right
Therapeutic Targeting of B Cells for Rheumatic Autoimmune Diseases
Francisco Lozano
Pharmacological Reviews, 2011
View PDFchevron_right
Comment on "Chaperone Activity of B-Crystallin Is Responsible for Its Incorrect Assignment as an Autoantigen in Multiple Sclerosis
Jeffrey Bajramovic
The Journal of Immunology, 2011
View PDFchevron_right
immunological comparison of HS proteins and alpha-crystallin
Bob Augusteyn
View PDFchevron_right
The protective effect of α-crystallin against acute inflammation in mice
Jayakumar Rajadas
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2005
View PDFchevron_right
Therapeutic Intervention in Multiple Sclerosis with Alpha B-Crystallin: A Randomized Controlled Phase IIa Trial
Edna Venneker
PLOS ONE, 2015
View PDFchevron_right
B cells and CD22 are dispensable for the immediate antiinflammatory activity of intravenous immunoglobulins in vivo
Markus Biburger, Falk Nimmerjahn
European Journal of Immunology, 2012
View PDFchevron_right
immunochemical properties of alpha-crystallin
Bob Augusteyn
View PDFchevron_right
Novelties in the field of autoimmunity - 1st Saint Petersburg congress of autoimmunity, the bridge between east and west
Mally Ehrenfeld
Autoimmunity reviews, 2017
View PDFchevron_right
An HLA-DRB1∗0402 derived peptide (HV3 65-79) prevents collagen-induced arthritis in HLA-DQ8 transgenic mice
Harvinder Luthra
Human Immunology, 1999
View PDFchevron_right
Intravenous immunoglobulin treatment of experimental T cell-mediated autoimmune disease. Upregulation of T cell proliferation and downregulation of tumor necrosis factor alpha secretion
Raanan Margalit
Journal of Clinical Investigation, 1994
View PDFchevron_right
International Journal of Pharmaceutical Technology and Biotechnology 51 *Corresponding Author: UNDERSTANDING AUTOIMMUNE DISEASE: AN UPDATE REVIEW
Rina Kartika
View PDFchevron_right
Therapy of Autoimmune Diseases with Antibody to Immune Response Gene Products or to T-Cell Surface Markers
dennis mitchell
Annals of the New York Academy of Sciences, 1986
View PDFchevron_right
Therapeutic Effects of Systemic Administration of Chaperone αB-Crystallin Associated with Binding Proinflammatory Plasma Proteins
Sara Brownell
Journal of Biological Chemistry, 2012
View PDFchevron_right
A Novel Synthetic Peptide for the Specific Treatment of Lupus: Clinical Effects and Mechanism of Action The Mosaic of Autoimmunity
Amir Sharabi
View PDFchevron_right
B-lymphocyte stimulator/a proliferation-inducing ligand heterotrimers are elevated in the sera of patients with autoimmune disease and are neutralized by atacicept and B cell maturation antigen-immunoglobulin
Stacey Dillon, Brandon Harder
Arthritis Research & Therapy, 2010
View PDFchevron_right
The link between small heat shock proteins and the immune system
Johannes van Noort
The International Journal of Biochemistry & Cell Biology, 2012
View PDFchevron_right
Application of Monoclonal Antibody Therapies in Autoimmune Diseases
Gabriella Sarmay, József Prechl
View PDFchevron_right
Editorial: Biological drugs and biosimilars in autoimmune diseases
Anna Wajda
Frontiers in Pharmacology
View PDFchevron_right
T and B lymphocytes in alpha-chain disease
Arsalan Kharazmi
British journal of cancer, 1978
View PDFchevron_right
B Cell Modulation Strategies in Autoimmunity: The SLE Example
Maria Rosado
Current Pharmaceutical Design, 2011
View PDFchevron_right
Impaired Invariant Chain Degradation and Antigen Presentation and Diminished Collagen-Induced Arthritis in Cathepsin S Null Mice
Daysianne de Lira, Jeffrey Stock
Immunity, 1999
View PDFchevron_right